当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:63.46亿  总市值:64.36亿
流通股本:12.90亿   总股本:13.08亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金23,414,143,871.949,922,819,614.2855,386,611,479.0937,340,831,696.6
  收到其他与经营活动有关的现金234,459,165.04580,491,334.35273,819,883.97146,683,981.35
  经营活动现金流入小计23,648,603,036.9810,503,310,948.6355,660,431,363.0637,487,515,677.95
  购买商品、接受劳务支付的现金27,143,786,798.3814,548,411,289.4652,758,765,664.9440,357,961,259.13
  支付给职工以及为职工支付的现金541,205,675.89310,417,803.151,008,889,614.83786,375,678.4
  支付的各项税费577,927,562.29279,076,591.64905,693,399766,154,612.63
  支付其他与经营活动有关的现金545,461,922.81559,906,339.75895,273,755.34553,758,596.04
  经营活动现金流出小计28,808,381,959.3715,697,812,02455,568,622,434.1142,464,250,146.2
  经营活动产生的现金流量净额-5,159,778,922.39-5,194,501,075.3791,808,928.95-4,976,734,468.25
二、投资活动产生的现金流量:
  收回投资收到的现金385,000,000215,000,0001,249,000,000959,000,000
  取得投资收益收到的现金1,114,544.52674,808.226,464,475.714,252,843.68
  处置固定资产、无形资产和其他长期资产收回的现金净额33,610,081.534,102,435.64269,104,946.566,964,687.53
  投资活动现金流入小计419,724,626.05219,777,243.861,524,569,422.27970,217,531.21
  购建固定资产、无形资产和其他长期资产支付的现金108,470,362.2369,156,484.45251,374,104.16177,192,879.45
  投资支付的现金328,000,000188,000,0001,468,900,0001,249,000,000
  取得子公司及其他营业单位支付的现金51,917.2251,917.22--
  投资活动现金流出小计436,522,279.45257,208,401.671,720,274,104.161,426,192,879.45
  投资活动产生的现金流量净额-16,797,653.4-37,431,157.81-195,704,681.89-455,975,348.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金22,940,000-71,595,18035,007,745
  其中:子公司吸收少数股东投资收到的现金22,940,000-71,595,18035,007,745
  取得借款收到的现金13,543,306,206.27,123,845,116.0316,463,072,465.8112,910,163,704.25
  发行债券收到的现金5,000,000,0002,000,000,0005,572,528,735.855,572,528,735.85
  收到其他与筹资活动有关的现金--44,336,88039,406,740
  筹资活动现金流入小计18,566,246,206.29,123,845,116.0322,151,533,261.6618,557,106,925.1
  偿还债务支付的现金13,148,139,985.794,900,063,881.9721,779,415,024.5114,282,441,596.12
  分配股利、利润或偿付利息支付的现金460,003,894.71103,496,069.24617,612,347.6545,736,766.77
  其中:子公司支付给少数股东的股利、利润91,531,143.62-124,982,809.89108,624,768.84
  支付其他与筹资活动有关的现金46,977,852.7822,112,767.93185,436,435.51132,351,136.49
  筹资活动现金流出小计13,655,121,733.285,025,672,719.1422,582,463,807.6214,960,529,499.38
  筹资活动产生的现金流量净额4,911,124,472.924,098,172,396.89-430,930,545.963,596,577,425.72
五、现金及现金等价物净增加额-265,452,102.87-1,133,759,836.29-534,826,298.9-1,836,132,390.77
  加:期初现金及现金等价物余额2,393,310,157.652,393,310,157.652,928,136,456.552,928,136,456.55
  期末现金及现金等价物余额2,127,858,054.781,259,550,321.362,393,310,157.651,092,004,065.78
补充资料:
  净利润378,501,024.19-832,668,876.52-
  资产减值准备4,212,882.79-25,113,091.63-
  固定资产和投资性房地产折旧66,068,267.74-132,876,091.13-
  无形资产摊销14,401,471.88-32,063,214.79-
  长期待摊费用摊销5,636,207.55-28,624,025.16-
  处置固定资产、无形资产和其他长期资产的损失-2,970,207.79--293,312,740.32-
  固定资产报废损失136,599.89---
  公允价值变动损失-410,597.27--282,526.03-
  财务费用139,864,841.66-309,014,785.81-
  投资损失-3,530,736.72--4,793,861.74-
  递延所得税-25,790,447.46--25,233,071.69-
  其中:递延所得税资产减少-16,542,056.63--30,054,456.86-
    递延所得税负债增加-9,248,390.83-4,821,385.17-
  存货的减少69,482,728.16--617,697,096.08-
  经营性应收项目的减少-5,234,532,103.42--1,584,295,480.33-
  经营性应付项目的增加-711,235,204.89-947,267,571.58-
  现金的期末余额2,127,858,054.78-2,393,310,157.65-
  减:现金的期初余额2,393,310,157.65-2,928,136,456.55-
  现金及现金等价物的净增加额-265,452,102.87--534,826,298.9-
公告日期2026-08-292026-04-302026-04-112025-10-31
审计意见(境内)标准无保留意见
TOP↑